Luxor Capital Group Reveals New 6.1% Stake in AMC Entertainment Holdings Inc (AMC)

Hedge fund Luxor Capital Group, managed by Christian Leone, has disclosed a new stake in AMC Entertainment Holdings Inc (NYSE:AMC). The stake contains around 1.28 million class A shares, equal to 6.1% of the class A common stock. The company went public earlier in December, and since then its stock has gained almost 10%. The value of Luxor’s stake, at the current share price of AMC Entertainment Holdings amounts to $26.51 million.

Christian Leone

In its initial public offering, AMC Entertainment Holdings Inc (NYSE:AMC), a cinema operator, offered around 18.42 million class A shares at a price of $18.00 apiece, The underwriters also received the possibility to buy additional 2.63 million shares as over allotment options. In this way, the net proceeds from the offering amounted to $359.1 million.

Earlier, Ken Griffin‘s Citadel Investment Group disclosed holding a total of 7.7% of the AMC Entertainment Holdings Inc (NYSE:AMC) class A common stock, its holding amassing over 1.6 million shares. The position has been boosted from some 936,300 shares held according to Citadel’s latest 13F.

Recently the company launched a commencing tender offer, under the terms of which it plans to acquire $600 million of its outstanding 8.75% Senior Notes due 2019. The offer will expire on February 12, and the holders of the Notes will receive around 1,038 per $1,000 of the principal amount of Notes, plus $30.00 as consent payment.

Among other investors with significant positions in AMC Entertainment Holdings Inc (NYSE:AMC). is Paulson & Co, led by John Paulson, which holds 4.95 million shares of the company as of the end of September 2013, the reported value of the stake amounting to $338.77 million. Another one is Mario Gabelli‘s GAMCO Investors with a holding of to 2.30 million shares, with a reported value of $157.300

Disclosure: none

Recommended Reading:

Wilbur Ross Adds to EXCO Resources Inc (XCO) Holding Following the Rights Offering

Daniel Loeb Discloses Big Stake in The Dow Chemical Company (DOW); Asks for a Strategic Review

Jeff Smith Sends Letter to Darden Restaurants, Inc. (DRI)’s CEO; Asks to Delay Red Lobster Spin-off

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!